Zhaoke Ophthalmology Pharmaceutical is based in Guangzhou, Guangdong, China. Zhaoke Ophthalmology Pharmaceutical has raised $395M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2021. The round record for Zhaoke Ophthalmology Pharmaceutical runs through 2021; nothing later has been disclosed. Investors on record include GIC, Hillhouse Capital, TPG, Loyal Valley Capital, Orbimed, Aier Eye Hospital and 5 others. 11 distinct backers are named across the disclosed rounds.
Zhaoke Ophthalmology Pharmaceutical at a glance
Total raised
$395M
Latest round
IPO
Latest round date
April 2021
Headquarters
Guangzhou, Guangdong, China
Notable investors
GIC, Hillhouse Capital, TPG, Loyal Valley Capital, Orbimed, Aier Eye Hospital, Matthews International Capital Management, CaaS Capital
Frequently asked about Zhaoke Ophthalmology Pharmaceutical funding
How much has Zhaoke Ophthalmology Pharmaceutical raised?
Zhaoke Ophthalmology Pharmaceutical has raised $395M in total disclosed funding across the rounds on record.
Who has invested in Zhaoke Ophthalmology Pharmaceutical?
GIC, Hillhouse Capital, TPG, Loyal Valley Capital, Orbimed, Aier Eye Hospital are named among the investors backing Zhaoke Ophthalmology Pharmaceutical.
What was the latest Zhaoke Ophthalmology Pharmaceutical funding round?
The most recent disclosed round is an IPO, announced in April 2021.
Where is Zhaoke Ophthalmology Pharmaceutical based?
Zhaoke Ophthalmology Pharmaceutical is based in Guangzhou, Guangdong, China.
When did Zhaoke Ophthalmology Pharmaceutical last raise?
The last disclosed Zhaoke Ophthalmology Pharmaceutical round closed in April 2021 at IPO.
Totals shown for Zhaoke Ophthalmology Pharmaceutical aggregate every disclosed round on file. To see how that compares, browse the companies in Guangzhou and the investors behind them below.
Companies related to Zhaoke Ophthalmology Pharmaceutical (36)
